NNBP OTC
Nanobac Pharmaceuticals, Incorporated
1W: +0.0%
1M: +9900.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -0.0%
5Y: -85.7%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$18K
-92.2% ▼
5Y CAGR: +8.8%
Gross Profit
$3K
-97.9% ▼
5Y CAGR: -15.6%
Operating Income
$5M
+2.1% ▲
5Y CAGR: +27.2%
Net Income
-$7M
-32.2% ▼
EPS (Diluted)
$0.00
+100.0% ▲
EBITDA
-$6M
-40.1% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2003 | FY2004 | FY2005 | FY2006 | FY2007 |
|---|---|---|---|---|---|
| Revenue | $483K | $358K | $657K | $225K | $18K |
| YoY Growth | +4078.4% | -25.8% | +83.3% | -65.7% | -92.2% |
| Cost of Revenue | $333K | $100K | $229K | $80K | $15K |
| Gross Profit | $150K | $258K | $427K | $145K | $3K |
| Gross Margin | 31.0% | 72.0% | 65.1% | 64.5% | 17.6% |
| R&D Expenses | $540K | $2M | $1M | $2M | $1M |
| SG&A Expenses | $2M | $5M | $1M | $2M | $3M |
| Operating Expenses | $3M | $8M | $3M | $5M | $5M |
| Operating Income | $3M | $8M | $3M | $5M | $5M |
| Operating Margin | 559.3% | 2120.9% | 432.0% | 2139.0% | 27891.8% |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$3M | -$8M | -$4M | -$5M | -$7M |
| Tax Expense | $999K | $274K | $850K | $159K | $2M |
| Net Income | -$4M | -$8M | -$4M | -$5M | -$7M |
| Net Margin | -766.2% | -2197.4% | -561.4% | -2209.5% | -37319.7% |
| EPS (Diluted) | $-0.05 | $-0.05 | $-0.02 | $-0.02 | $0.00 |
| EBITDA | -$3M | -$7M | -$3M | -$4M | -$6M |
| Shares Outstanding | 67M | 153M | 189M | 199M | 0 |